Vitamin E succinate induces fas-mediated apoptosis in estrogen receptor- negative human breast cancer cells

Cancer Research

Volumn 57, Issue 5, 1997, Pages 881-890

  Turley, Jennifer M ^a   Fu, Tao ^a   Ruscetti, Francis W ^a   Mikovits, Judy A ^a   Bertolette III, Daniel C ^a   Birchenall Roberts, Maria C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL SUCCINATE; ESTROGEN RECEPTOR; FAS ANTIGEN; MESSENGER RNA;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ANALYSIS;

APOPTOSIS; BREAST NEOPLASMS; CELL MEMBRANE; FAS LIGAND PROTEIN; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH INHIBITORS; HUMANS; MEMBRANE GLYCOPROTEINS; OLIGONUCLEOTIDES, ANTISENSE; RECEPTORS, ESTROGEN; RNA, MESSENGER; RNA, NEOPLASM; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; VITAMIN E;

EID: 0031025369     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Meng-er, H., Yu-chen, Y., Shu-rong, C., Jin-ren, C., Jia-Xiang, L., Lin, Z., Long-jun, G., and Zhen-yi, W. Use of all-trans retinoic acid in the treatment of acute promy-elocytic leukemia. Blood, 72: 567-572, 1988.
2. Castaigne, S., Chomienne, C., Daniel, M. T., Ballerini, P., Berger, R., Fenaux, P., and Degos, L. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood, 76: 1704-1709, 1990.
3. Boscoboinik, D., Szewezyk, A., Hensey, C., and Azzi, A. Inhibition of cell proliferation by alpha-tocopherol: role of protein kinase C. J. Biol. Chem., 266: 6188-6194, 1991.
4. Boscoboinik, D., Szewezyk, A., and Azzi, A. Alpha-tocopherol (vitamin E) regulates vascular smooth muscle cell proliferation and protein kinase C activity. Arch. Biochem. Biophys., 286: 264-269, 1991.
5. Turley, J. M., Sanders, B. G., and Kline, K. RRR-alpha-tocopheryl succinate modulation of human promyelocytic leukemia (HL-60) cell proliferation and differentiation. Nutr. Cancer, 18: 201-213, 1992.
6. Turley, J. M., Funakoshi, S., Ruscetti, F. W., Kasper, J., Murphy, W. J., Longo, D. L., and Birchenall-Roberts, M. C. Growth inhibition and apoptosis of RL human B-lymphoma cells by vitamin E succinate and retinoic acid: role for transforming growth factor β. Cell Growth & Differ., 6: 655-663, 1995.
7. Charpentier, A., Groves, S., Simmons-Menchaca, M., Turley, J., Zhao, B., Sanders, B. G., and Kline, K. RRR-alpha-tocopheryl succinate inhibits proliferation and enhances secretion of transforming growth factor-β (TGF-β) by human breast cancer cells. Nutr. Cancer, 19: 225-239, 1993.
8. Fariss, M. W., Fortuna, M. B., Everett, C. K., Smith, J. D., Trent, D. F., and Djuric, Z. The selective antiproliferative effects of alpha-tocopheryl hemisuccinate and cholesteryl hemisuccinate on murine leukemia cells results from the action of the intact compounds. Cancer Res., 54: 3346-3351, 1994.
9. Benner, S. E., Winn, R. J., Lippman, S. M., Poland, J., Hansen, K. S., Luna, M. A., and Hong, W. K. Regression of oral leukoplakia with alpha-tocopherol: a community clinical oncology program chemoprevention study. J. Natl. Cancer Inst., 85: 44-47, 1993.
10. Jaakkola, K., Lahteenmaki, P., Laakso, J., Harju, E., Tykka, H., and Mahlberg, K. Treatment with antioxidant and other nutrients in combination with chemotherapy and irradiation in patients with small-cell lung cancer. Anticancer Res., 12: 599-606, 1992.
11. Prasad, K. N., and Edwards-Prasad, J. Vitamin E and cancer prevention. Recent advances and future potentials. J. Am. Coll. Nutr., 11: 487-500, 1992.
12. Kelloff, G. J., Crowell, J. A., Boone, C. W., Steele, V. E., Lubet, R. A., Greenwald, P., Alberts, D. S., Covey, J. M., Doody, L. A., Knapp, G. G., Nayfield, S., Parkinson, D. R., Prasad, V. K., Prorok, P. C., Sausville, E. A., and Sigman, C. C. Clinical development plans for cancer chemopreventive agents. J. Cell. Biochem. Suppl., 20: 282-294, 1994.
13. Bendich, A., and Machlin, L. J. Safety of oral intake of vitamin E. Am. J. Clin. Nutr., 48: 612-619, 1988.
14. Niki, E., Yamamoto, Y., Komour, M., and Miyana, Y. Inhibition of oxidation of biomembranes by tocopherol. Vitamin E: biochemistry and health implications. Ann. NY Acad. Sci., 539: 23-25, 1989.
15. Helson, L., Verma, M., and Helson, C. Vitamin E and human neuroblastoma. In: F. L. Meyskens and K. N. Prasad (eds.), Modulation and Mediation of Cancer by Vitamins, pp. 258-265, Basel: Karger, 1983.
16. Slack, R., and Proulx, P. Studies on the effects of vitamin E on neuroblastoma NIE 115 cells. Nutr. Cancer, 12: 75-82, 1989.
17. Cohrs, R. J., Torelli, S., Prasad, K. N., Edwards-Prasad, J., and Sharma, O. K. Effect of vitamin E succinate and a cAMP stimulating agent on the expression of c-myc, N-myc and H-ras in murine neuroblastoma cells. Int. J. Dev. Neurosci., 9: 187-194, 1991.
18. Prasad, K. N., Cohrs, R. J., and Sharma, O. K. Decreased expression of c-myc and H-ras oncogenes in vitamin E succinate induced morphologically differentiated murine B-16 melanoma cells in culture. Biochem. Cell Biol., 68: 1250-1255, 1990.
19. Prasad, K. N., and Edwards-Prasad, J. Effects of tocopherol (vitamin E) acid succinate on morphological alterations and growth inhibition in melanoma cells in culture. Cancer Res., 42: 550-555, 1982.
20. Kline, K., Cochran, G. S., and Sanders, B. G. Growth-inhibitory effects of vitamin E succinate on retrovirus-transformed tumor cells in vitro. Nutr. Cancer, 14: 27-41, 1990.
21. Prasad, K. N. Mechanisms of action of vitamin E on mammalian tumor cell lines in culture. In: C. Grobstein (ed.), Nutrition, Growth, and Cancer, pp. 363-375. New York: Alan R. Liss, 1988.
22. Sahu, S. N., Edwards-Prasad, J., and Prasad, K. N. Effect of alpha tocopheryl succinate on adenylate cyclase activity in murine neuroblastoma cells in culture. J. Am. Coll. Nutr., 7: 285-293, 1988.
23. Torelli, S., Masoudi, F., and Prasad, K. N. Effect of tocopheryl succinate actívíty on cyclic AMP-dependent protein kinase activity in B16 melanoma cells in culture. Cancer Lett., 39: 129-136, 1988.
24. Chatelain, E., Boscoboinik, D. O., Bartoli, G. M., Kagan, V. E., Gey, F. K., Packer, L., and Azzi, A. Inhibition of smooth muscle cell proliferation and protein kinase C activity by tocopherols and tocotrienols. Biochim. Biophys. Acta, 1176: 83-89, 1993.
25. Mymryk, J. S., Shire, K., and Bayley, S. T. Induction of apoptosis by adenovirus type 5 E1A in rat cell requires a proliferation block. Oncogene, 9: 1187-1193, 1994.
26. Heintz, N. Cell death and the cell cycle: a relationship between transformation and neurodegradation? Trends Biochem. Sci., 18: 157-159, 1993.
27. Gerschenson, L. E., and Rotello, R. J. Apoptosis and cell proliferation are terms of the growth equation. In: L. D. Tomei and F. O. Cope (eds.), Apoptosis: The Molecular Basis of Cell Death, pp. 175-192. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1991.
28. Wyllie, A. H. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Metastasis Rev., 11: 95-103, 1992.
29. Hickman, J. A. Apoptosis induced by anticancer drugs. Cancer Metastasis Rev., 11: 121-139, 1992.
30. Compton, M. M. A biochemical hallmark of apoptosis: internucleosomal degradation of the genome. Cancer Metastasis Rev., 11: 105-119, 1992.
31. Tenniswood, M. P., Guenette, R. S., Latkins, J., Mooibroek, M., Wong, P., and Welsh, J-E. Active cell death in hormone-dependent tissues. Cancer Metastasis Rev., 11: 197-220, 1992.
32. Li, C., Jenkins, C. W., Nichols, M. A., and Xioong, Y. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene, 9: 2261-2268, 1994.
33. Miyashita, T., Krajewska, S., Krajewska, M., Wang, H. G., Lin, H. K., Liebermann, D. A., Hoffman, B., and Reed, J. C. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene, 9: 1799-1805, 1994.
34. Owen-Schaub, L. B., Zhang, W., Cusack, J. C., Angelo, L. S., Santee, S. M., Fujiwara, T., Roth, J. A., Deisseroth, A. B., Zhang, W-W., Kruzel, E., and Radinsky, R. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol. Cell. Biol., 15: 3032-3040, 1995.
35. Haldar, S., Negrini, M., Monne, M., Sabbioni, S., and Croce, C. M. Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res., 54: 2095-2097, 1994.
36. Chiou, S-K., Rao, L., and White, E. Bcl-2 blocks p53-dependent apoptosis. Mol. Cell. Biol., 14: 2556-2563, 1994.
37. 2 in breast carcinoma cells. Oncogene, 10: 2297-2305, 1995.
38. Muzio, M., Chinnaiyan, A. M., Kischkel, F. C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J. D., Zhang, M., Gentz, R., Mann, M., Krammer, P. H., Peter, M. E., and Dixit, V. M. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell, 85: 817-827, 1996.
39. Duan, H., Chinnaiyan, A. M., Hudson, P. L., Wing, J. P., He, W. W., and Dixit, V. M. ICE-LAP3, a novel mammalian homologue of the Caenorhabditis elegans cell death protein Ced-3 is activated during Fas- and tumor necrosis factor-induced apoptosis. J. Biol. Chem., 271: 1621-1625, 1996.
40. Silvestrini, R., Veneroni, S., Daidone, M. G., Benini, E., Boracchi, P., Mezzetti, M., Di Fronzo, G., Rilke, F., and Veronesi, U. The bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients. J. Natl. Cancer Inst., 86: 499-504, 1994.
41. Mazars, R., Spinardi, L., BenCheikh, M., Simony-Lafontaine, J., Jeanteur, P., and Theillet, C. p53 mutations occur in aggressive breast cancer. Cancer Res., 52: 3918-3923, 1992.
42. Kiguchi, K., Glesne, D., Chubb, C. H., Fujiki, H., and Huberman, E. Differential induction of apoptosis in human breast tumor cells by okadaic acid and related inhibitors of protein phosphatase 1 and 2A. Cell Growth & Differ., 5: 995-1004, 1994.
43. Turley, J. M., Falk, L. A., Ruscetti, F. W., Kasper, J. J., Francomano, T., Fu, T., Bang, O., and Birchenall-Roberts, M. C. Transforming growth factor β1 functions in monocytic differentiation of hematopoietic cells through autocrine and paracrine mechanisms. Cell Growth & Differ., 8: 1535-1544, 1996.
44. Hoffeld, J. T. Agents which block membrane lipid peroxidation enhance mouse spleen cell immune activities in vitro: relationship to the enhancing activity of 2-mercaptoethanol. Eur. J. Immunol., 11: 371-376, 1981.
45. Schreck, R., Rieber, P., and Baeuerle, R. A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J., 10: 2247-2258, 1991.
46. Gavrieli, Y., Sherman, Y., and Ben-Sasson, S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol., 119: 493-501, 1992.
47. Martin, S. J., Green, D. R., and Cotter, T. G. Dicing with death: dissecting the components of the apoptotic machinery. Trends Biochem. Sci., 19: 26-30, 1994.
48. Yonehara, S., Ishii, A., and Yonehara, M. A cell-killing antibody (anti-Fas) to a cell surface antigen co-downregulation with the receptor of tumor necrosis factor. J. Exp. Med., 169: 1747-1756, 1989.
49. Ogasawara, J., Suda, T., and Nagata, S. Selective apoptosis of CD4+CD8+ thymocytes by the anti-Fas antibody. J. Exp. Med., 181: 485-491, 1995.
50. Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitmura, Y., Itoh, N., Suda, T., and Nagata, S. Lethal effect of the anti-Fas antibody in mice. Nature (Lond.), 364: 806-809, 1993.
51. Coney, L. R., Daniel, P. T., Sanborn, D., Dhein, J., Debatin, K.-M., Krammer, P. H., and Zurawski, V. R. J. Apoptotic cell death induced by a mouse-human antí-Apo-1 chímeric antibody leads to tumor regression. Int. J. Cancer, 58: 562-567, 1994.
52. Schulze-Osthoff, K. The Fas/APO-1 receptor and its deadly ligand. Trends Cell Biol., 4: 421-426, 1995.
53. Chinnaiyan, A. M., O'Rourke, K., Tewari, M., and Dixit, V. M. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell, 81: 505-512, 1995.
54. Zhao, B., Yu, W., Kline, K., and Sanders, B. Vitamin E succinate induction of apoptosis in MCF-7 human breast cancer cells. Proc. Am. Assoc. Cancer Res., 37: 285, 1996.
55. Leithauser, F., Dhein, J., Mechterscheimer, G., Koretz, K., Bruderlein, S., Henne, C., Schmidt, A., Debatin, K., Krammer, P. H., and Moller, P. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Invest., 69: 415-429, 1993.
56. Perry, R. R., Kang, Y., and Greaves, B. Effects of tamoxifen on growth and apoptosis of estrogen-dependent and-independent human breast cancer cells. Ann. Surg. Oncol., 2: 238-245, 1995.
57. Cleveland, J. L., and Ihle, J. N. Contenders in FasL/TNF death signaling. Cell, 81: 479-482, 1995.
58. Gannon, J. V., Greaves, R., Iggo, R., and Lane, D. P. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J., 9: 1595-1602, 1990.
59. Beckwith, M., Ruscetti, F. W., Sing, G. W., Urba, W. J., and Longo, D. L. Anti-IgM induces transforming growth factor-β sensitivity in a human B-lymphoma cell line: inhibition of growth is associated with a downregulation of mutant p53. Blood, 85: 2461-2470, 1995.
60. Bargou, R. C., Daniel, P. T., Mapara, M. Y., Bommert, K., Wagener, C., Kallinich, B., Royer, H. D., and Dorken, B. Expression of the bcl-2 gene family in normal and malignant breast tissue: low bax-α expression in tumor cells correlates with resistance towards apoptosis. Int. J. Cancer, 60: 854-859, 1995.
61. Qian, M., Sanders, B. G., and Kline, K. RRR-α-tocopheryl succinate induces apoptosis in avian retrovirus-transformed lymphoid cells. Nutr. Cancer, 25: 9-26, 1996.